PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB • US7194051022

38.62 USD
-0.18 (-0.46%)
At close: Feb 17, 2026
38.6 USD
-0.02 (-0.05%)
After Hours: 2/17/2026, 6:44:35 PM
Fundamental Rating

6

Taking everything into account, PLAB scores 6 out of 10 in our fundamental rating. PLAB was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making PLAB a very profitable company, without any liquidiy or solvency issues. PLAB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • PLAB had positive earnings in the past year.
  • In the past year PLAB had a positive cash flow from operations.
  • Each year in the past 5 years PLAB has been profitable.
  • Each year in the past 5 years PLAB had a positive operating cash flow.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • PLAB has a Return On Assets of 7.56%. This is in the better half of the industry: PLAB outperforms 72.57% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.62%, PLAB is in the better half of the industry, outperforming 74.34% of the companies in the same industry.
  • PLAB's Return On Invested Capital of 10.17% is amongst the best of the industry. PLAB outperforms 80.53% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PLAB is in line with the industry average of 10.70%.
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROIC 10.17%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • PLAB's Profit Margin of 16.06% is fine compared to the rest of the industry. PLAB outperforms 74.34% of its industry peers.
  • PLAB's Profit Margin has improved in the last couple of years.
  • PLAB has a better Operating Margin (24.51%) than 82.30% of its industry peers.
  • PLAB's Operating Margin has improved in the last couple of years.
  • The Gross Margin of PLAB (35.30%) is worse than 61.95% of its industry peers.
  • In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PLAB is creating some value.
  • The number of shares outstanding for PLAB has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PLAB has less shares outstanding
  • The debt/assets ratio for PLAB has been reduced compared to a year ago.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.11 indicates that PLAB is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.11, PLAB is in line with its industry, outperforming 52.21% of the companies in the same industry.
  • PLAB has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.00, PLAB belongs to the best of the industry, outperforming 85.84% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, PLAB is in the better half of the industry, outperforming 74.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.11
ROIC/WACC0.94
WACC10.76%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PLAB has a Current Ratio of 5.37. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 5.37, PLAB is doing good in the industry, outperforming 75.22% of the companies in the same industry.
  • PLAB has a Quick Ratio of 4.99. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 4.99, PLAB is doing good in the industry, outperforming 78.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.37
Quick Ratio 4.99
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. Growth

3.1 Past

  • PLAB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.53%.
  • Measured over the past years, PLAB shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.81% on average per year.
  • PLAB shows a decrease in Revenue. In the last year, the revenue decreased by -2.04%.
  • Measured over the past years, PLAB shows a small growth in Revenue. The Revenue has been growing by 6.85% on average per year.
EPS 1Y (TTM)2.53%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%1.69%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%-3.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.62% on average over the next years.
  • PLAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.23% yearly.
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

  • PLAB is valuated rather expensively with a Price/Earnings ratio of 19.02.
  • 92.92% of the companies in the same industry are more expensive than PLAB, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of PLAB to the average of the S&P500 Index (27.16), we can say PLAB is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 17.78 indicates a rather expensive valuation of PLAB.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 89.38% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of PLAB to the average of the S&P500 Index (28.10), we can say PLAB is valued slightly cheaper.
Industry RankSector Rank
PE 19.02
Fwd PE 17.78
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • PLAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PLAB is cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PLAB is valued cheaply inside the industry as 82.30% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 38.29
EV/EBITDA 5.63
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PLAB does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of PLAB may justify a higher PE ratio.
PEG (NY)2.71
PEG (5Y)0.62
EPS Next 2Y5.62%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield 0%

PHOTRONICS INC

NASDAQ:PLAB (2/17/2026, 6:44:35 PM)

After market: 38.6 -0.02 (-0.05%)

38.62

-0.18 (-0.46%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-10
Earnings (Next)02-25
Inst Owners94.12%
Inst Owner Change-0.55%
Ins Owners3.91%
Ins Owner Change0.58%
Market Cap2.28B
Revenue(TTM)849.29M
Net Income(TTM)136.40M
Analysts85
Price Target43.2 (11.86%)
Short Float %5.45%
Short Ratio1.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.53%
Min EPS beat(2)29.38%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)12.6%
Min EPS beat(4)-19.14%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)2.09%
EPS beat(12)6
Avg EPS beat(12)2.67%
EPS beat(16)9
Avg EPS beat(16)6.93%
Revenue beat(2)2
Avg Revenue beat(2)1.95%
Min Revenue beat(2)0.82%
Max Revenue beat(2)3.08%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)3.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.37%
Revenue beat(12)5
Avg Revenue beat(12)-1.19%
Revenue beat(16)8
Avg Revenue beat(16)-0.48%
PT rev (1m)-2.04%
PT rev (3m)28.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.72%
EPS NY rev (1m)0%
EPS NY rev (3m)6.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.76%
Valuation
Industry RankSector Rank
PE 19.02
Fwd PE 17.78
P/S 2.69
P/FCF 38.29
P/OCF 9.2
P/B 1.94
P/tB 1.94
EV/EBITDA 5.63
EPS(TTM)2.03
EY5.26%
EPS(NY)2.17
Fwd EY5.63%
FCF(TTM)1.01
FCFY2.61%
OCF(TTM)4.2
OCFY10.86%
SpS14.38
BVpS19.87
TBVpS19.87
PEG (NY)2.71
PEG (5Y)0.62
Graham Number30.13
Profitability
Industry RankSector Rank
ROA 7.56%
ROE 11.62%
ROCE 12.7%
ROIC 10.17%
ROICexc 15.86%
ROICexgc 15.86%
OM 24.51%
PM (TTM) 16.06%
GM 35.3%
FCFM 7.01%
ROA(3y)7.8%
ROA(5y)7.34%
ROE(3y)12.05%
ROE(5y)11.43%
ROIC(3y)12.29%
ROIC(5y)11.75%
ROICexc(3y)20.09%
ROICexc(5y)18.3%
ROICexgc(3y)20.09%
ROICexgc(5y)18.3%
ROCE(3y)15.36%
ROCE(5y)14.68%
ROICexgc growth 3Y-10.62%
ROICexgc growth 5Y18.95%
ROICexc growth 3Y-10.62%
ROICexc growth 5Y19.05%
OM growth 3Y-1.57%
OM growth 5Y18.52%
PM growth 3Y3.68%
PM growth 5Y23.71%
GM growth 3Y-0.36%
GM growth 5Y9.83%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 242.55%
Cap/Sales 22.16%
Interest Coverage 250
Cash Conversion 86.71%
Profit Quality 43.67%
Current Ratio 5.37
Quick Ratio 4.99
Altman-Z 4.11
F-Score6
WACC10.76%
ROIC/WACC0.94
Cap/Depr(3y)187.79%
Cap/Depr(5y)164.84%
Cap/Sales(3y)17.34%
Cap/Sales(5y)16.42%
Profit Quality(3y)93.18%
Profit Quality(5y)98.28%
High Growth Momentum
Growth
EPS 1Y (TTM)2.53%
EPS 3Y0.83%
EPS 5Y30.81%
EPS Q2Q%1.69%
EPS Next Y7.02%
EPS Next 2Y5.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y0.99%
Revenue growth 5Y6.85%
Sales Q2Q%-3.08%
Revenue Next Year5.7%
Revenue Next 2Y6.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.03%
EBIT growth 3Y-0.59%
EBIT growth 5Y26.64%
EBIT Next Year48.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.32%
FCF growth 3Y-28.46%
FCF growth 5Y-3.72%
OCF growth 1Y-5.22%
OCF growth 3Y-3.44%
OCF growth 5Y11.62%

PHOTRONICS INC / PLAB FAQ

What is the fundamental rating for PLAB stock?

ChartMill assigns a fundamental rating of 6 / 10 to PLAB.


Can you provide the valuation status for PHOTRONICS INC?

ChartMill assigns a valuation rating of 6 / 10 to PHOTRONICS INC (PLAB). This can be considered as Fairly Valued.


How profitable is PHOTRONICS INC (PLAB) stock?

PHOTRONICS INC (PLAB) has a profitability rating of 7 / 10.


What is the valuation of PHOTRONICS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PHOTRONICS INC (PLAB) is 19.02 and the Price/Book (PB) ratio is 1.94.